Description
SUDEEP PHARMA LIMITED (Exchange ticker 544619) will be added to the BSE IPO Index effective December 02, 2025, following its listing on BSE on November 28, 2025.
Summary
BSE has announced that SUDEEP PHARMA LIMITED (Exchange ticker: 544619) will be added to the BSE IPO Index effective at the open of Tuesday, December 02, 2025. The stock is being listed on BSE effective Friday, November 28, 2025. This is a routine index maintenance action following the company’s IPO listing.
Key Points
- SUDEEP PHARMA LIMITED (ticker: 544619) is being added to the BSE IPO Index
- Stock listing date on BSE: November 28, 2025 (Friday)
- Index addition effective date: December 02, 2025 (Tuesday) at market open
- This action is included in the end-of-day corporate action file (*.SDE)
- For queries, contact: bseindex@bseindia.com
Regulatory Changes
No regulatory changes. This is a standard index composition update following an IPO listing.
Compliance Requirements
No specific compliance requirements for market participants. This is an informational notice regarding index composition changes.
Important Dates
- November 28, 2025 (Friday): SUDEEP PHARMA LIMITED listing effective on BSE
- December 02, 2025 (Tuesday): Stock addition to BSE IPO Index effective at market open
Impact Assessment
Market Impact: Low. This is a routine index maintenance action following an IPO listing. The addition to the BSE IPO Index will affect index funds and ETFs tracking this index, requiring them to purchase shares of SUDEEP PHARMA LIMITED for portfolio rebalancing.
Operational Impact: Minimal. Index providers and passive fund managers tracking the BSE IPO Index will need to adjust their portfolios accordingly. The action has been included in the corporate action file for automated processing by market systems.
Impact Justification
Routine index addition following IPO listing; affects only index composition with minimal market-wide impact